TAD TITLOW: Open Payments
NPI 1073725669 · HENDERSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 147 payments from 23 companies in 2025. Trend: 2023 $2,046 · 2024 $1,957 · 2025 $2,199
Food & beverage: $2,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $330 |
| ABBVIE INC. | 27 | $319 |
| AstraZeneca Pharmaceuticals LP | 11 | $291 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $230 |
| Lilly USA, LLC | 15 | $193 |
| Amgen Inc. | 17 | $183 |
| GlaxoSmithKline, LLC. | 10 | $149 |
| Abbott Laboratories | 3 | $57 |
| PFIZER INC. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
Products named: Kerendia, MOUNJARO, Wegovy, VRAYLAR, TRELEGY ELLIPTA, FARXIGA, AIRSUPRA, OTEZLA.
Industry payments across TX — which companies pay providers there.
